Acadia Pharmaceuticals Inc (ACAD) returns
Acadia Pharmaceuticals returns over 10 years
$1,000 invested in Acadia Pharmaceuticals ten years ago was worth $912.27 at the close on October 30, 2026, with dividends reinvested: an average return of -0.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +2.2% | — | $1,022 | -0.9% |
| 3 months | -22.4% | — | $775.52 | +2.1% |
| Year to date | -22.9% | — | $770.87 | +11.7% |
| 1 year | -9.5% | — | $905.45 | +12.4% |
| 3 years | -7.4% | -2.5% | $926.23 | +88.5% |
| 5 years | +14.7% | +2.8% | $1,147 | +76.0% |
| 10 years | -8.8% | -0.9% | $912.27 | +316.6% |
Acadia Pharmaceuticals return by calendar year
| Year | ACAD | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -22.9% | +11.7% | -34.6% |
| 2025 | +45.6% | +17.7% | +27.8% |
| 2024 | -41.4% | +24.9% | -66.3% |
| 2023 | +96.7% | +26.2% | +70.5% |
| 2022 | -31.8% | -18.2% | -13.6% |
| 2021 | -56.3% | +28.7% | -85.1% |
| 2020 | +25.0% | +18.4% | +6.6% |
| 2019 | +164.6% | +31.2% | +133.3% |
| 2018 | -46.3% | -4.6% | -41.7% |
| 2017 | +4.4% | +21.7% | -17.3% |
| 2016 | -19.1% | +12.0% | -31.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ACAD financials · ACAD valuation
No forecast, no recommendation. This page describes Acadia Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.